Validation of the CREST model & Comparison with SCAI Shock Classification for Prediction of Circulatory Death in Resuscitated Out of Hospital Cardiac Arrest.

Circulatory Etiology Death Out-of-hospital cardiac arrest

Journal

European heart journal. Acute cardiovascular care
ISSN: 2048-8734
Titre abrégé: Eur Heart J Acute Cardiovasc Care
Pays: England
ID NLM: 101591369

Informations de publication

Date de publication:
28 May 2024
Historique:
received: 31 12 2023
revised: 01 05 2024
accepted: 27 05 2024
medline: 28 5 2024
pubmed: 28 5 2024
entrez: 28 5 2024
Statut: aheadofprint

Résumé

We validated the CREST model, a 5 variable score for stratifying risk of circulatory etiology death (CED) following out of hospital cardiac arrest (OHCA), and compared its discrimination with the SCAI shock classification. CED occurs in approximately a third of patients admitted after resuscitated OHCA. There is an urgent need for improved stratification of the OHCA patient on arrival to a cardiac arrest centre to improve patient selection for invasive interventions. The CREST model and SCAI shock classification were applied to a dual-centre registry of 723 patients with cardiac etiology OHCA, both with and without ST-elevation myocardial infarction, between May 2012 to December 2020. The primary endpoint was 30-day CED. Of 509 patients included (62.3 years, 75.4% male), 125 patients had CREST=0 (24.5%), 162 were CREST=1 (31.8%), 140 were CREST=2 (27.5%), 75 were CREST=3 (14.7%), 7 were CREST of 4 (1.4%) and no patients were CREST=5. CED was observed in 91 (17.9%) patients at 30 days [STEMI - 51/289 (17.6%); NSTEMI - 40/220 (18.2%)]. For the total population, and both NSTEMI & STEMI subpopulations, increasing CREST score was associated with increasing CED (all p<0.001). CREST score and SCAI classification had similar discrimination for the total population (AUC=0.72/calibration slope=0.95), NSTEMI cohort (AUC=0.75/calibration slope=0.940) and STEMI cohort (AUC=0.69 and calibration slope=0.925). AUC meta-analyses demonstrated no significant differences between the two classifications. The CREST model and SCAI shock classification have similar prediction for the development of CED after OHCA.

Sections du résumé

OBJECTIVE OBJECTIVE
We validated the CREST model, a 5 variable score for stratifying risk of circulatory etiology death (CED) following out of hospital cardiac arrest (OHCA), and compared its discrimination with the SCAI shock classification.
BACKGROUND BACKGROUND
CED occurs in approximately a third of patients admitted after resuscitated OHCA. There is an urgent need for improved stratification of the OHCA patient on arrival to a cardiac arrest centre to improve patient selection for invasive interventions.
METHODS METHODS
The CREST model and SCAI shock classification were applied to a dual-centre registry of 723 patients with cardiac etiology OHCA, both with and without ST-elevation myocardial infarction, between May 2012 to December 2020. The primary endpoint was 30-day CED.
RESULTS RESULTS
Of 509 patients included (62.3 years, 75.4% male), 125 patients had CREST=0 (24.5%), 162 were CREST=1 (31.8%), 140 were CREST=2 (27.5%), 75 were CREST=3 (14.7%), 7 were CREST of 4 (1.4%) and no patients were CREST=5. CED was observed in 91 (17.9%) patients at 30 days [STEMI - 51/289 (17.6%); NSTEMI - 40/220 (18.2%)]. For the total population, and both NSTEMI & STEMI subpopulations, increasing CREST score was associated with increasing CED (all p<0.001). CREST score and SCAI classification had similar discrimination for the total population (AUC=0.72/calibration slope=0.95), NSTEMI cohort (AUC=0.75/calibration slope=0.940) and STEMI cohort (AUC=0.69 and calibration slope=0.925). AUC meta-analyses demonstrated no significant differences between the two classifications.
CONCLUSIONS CONCLUSIONS
The CREST model and SCAI shock classification have similar prediction for the development of CED after OHCA.

Identifiants

pubmed: 38805012
pii: 7683762
doi: 10.1093/ehjacc/zuae070
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© The Author(s) 2024. Published by Oxford University Press on behalf of the European Society of Cardiology. All rights reserved. For commercial re-use, please contact reprints@oup.com for reprints and translation rights for reprints. All other permissions can be obtained through our RightsLink service via the Permissions link on the article page on our site—for further information please contact journals.permissions@oup.com.

Auteurs

Samuel A Watson (SA)

King's College Hospital NHS Foundation Trust, London, United Kingdom.
School of Cardiovascular and Metabolic Medicine & Sciences, BHF Centre of Excellence, King's College London, United Kingdom.

Shamika Mohanan (S)

Department of Biostatistics and Health Informatics, Institute of Psychiatry, Psychology and Neuroscience, King's College London, United Kingdom.

Muhamad Abdrazak (M)

King's College Hospital NHS Foundation Trust, London, United Kingdom.
School of Cardiovascular and Metabolic Medicine & Sciences, BHF Centre of Excellence, King's College London, United Kingdom.

Roman Roy (R)

King's College Hospital NHS Foundation Trust, London, United Kingdom.
School of Cardiovascular and Metabolic Medicine & Sciences, BHF Centre of Excellence, King's College London, United Kingdom.

Alexandra Parczewska (A)

Uniwersyteckie Centrum Kliniczne w Gdańsku, Poland.

Ritesh Kanyal (R)

King's College Hospital NHS Foundation Trust, London, United Kingdom.
School of Cardiovascular and Metabolic Medicine & Sciences, BHF Centre of Excellence, King's College London, United Kingdom.

Michael McGarvey (M)

King's College Hospital NHS Foundation Trust, London, United Kingdom.
School of Cardiovascular and Metabolic Medicine & Sciences, BHF Centre of Excellence, King's College London, United Kingdom.

Rafal Dworakowski (R)

King's College Hospital NHS Foundation Trust, London, United Kingdom.
School of Cardiovascular and Metabolic Medicine & Sciences, BHF Centre of Excellence, King's College London, United Kingdom.
Uniwersyteckie Centrum Kliniczne w Gdańsku, Poland.

Ian Webb (I)

King's College Hospital NHS Foundation Trust, London, United Kingdom.
School of Cardiovascular and Metabolic Medicine & Sciences, BHF Centre of Excellence, King's College London, United Kingdom.

Kevin O'Gallagher (K)

King's College Hospital NHS Foundation Trust, London, United Kingdom.
School of Cardiovascular and Metabolic Medicine & Sciences, BHF Centre of Excellence, King's College London, United Kingdom.

Narbeh Melikian (N)

King's College Hospital NHS Foundation Trust, London, United Kingdom.
School of Cardiovascular and Metabolic Medicine & Sciences, BHF Centre of Excellence, King's College London, United Kingdom.

Georg Auzinger (G)

King's College Hospital NHS Foundation Trust, London, United Kingdom.

Sameer Patel (S)

King's College Hospital NHS Foundation Trust, London, United Kingdom.

Miłosz J Jaguszewski (MJ)

Uniwersyteckie Centrum Kliniczne w Gdańsku, Poland.

Daniel Stahl (D)

Department of Biostatistics and Health Informatics, Institute of Psychiatry, Psychology and Neuroscience, King's College London, United Kingdom.

Ajay Shah (A)

King's College Hospital NHS Foundation Trust, London, United Kingdom.
School of Cardiovascular and Metabolic Medicine & Sciences, BHF Centre of Excellence, King's College London, United Kingdom.

Philip MacCarthy (P)

King's College Hospital NHS Foundation Trust, London, United Kingdom.
School of Cardiovascular and Metabolic Medicine & Sciences, BHF Centre of Excellence, King's College London, United Kingdom.

Jonathan Byrne (J)

King's College Hospital NHS Foundation Trust, London, United Kingdom.
School of Cardiovascular and Metabolic Medicine & Sciences, BHF Centre of Excellence, King's College London, United Kingdom.

Nilesh Pareek (N)

King's College Hospital NHS Foundation Trust, London, United Kingdom.
School of Cardiovascular and Metabolic Medicine & Sciences, BHF Centre of Excellence, King's College London, United Kingdom.

Classifications MeSH